Do GLP-1 drugs destroy muscle? Here's what the data says

What did @gregoryogallagher actually say?

Gregory O'Gallagher argues that GLP-1 medications don't cause muscle loss on their own. According to him, "what causes muscle loss is going to low in calories, not hitting your protein and not lifting heavy." He also singles out tirzepatide specifically, claiming its GIP component improves insulin sensitivity, metabolic health, and glucose uptake in muscle, calling this "a positive benefit even in lean people."

The video is framed as a myth-buster. He's pushing back on the common fear that semaglutide or tirzepatide will eat your muscle. And honestly? He's not entirely wrong. But the nuance he leaves out matters more than he lets on.

Does the science back this up?

Partially, yes. The claim that GLP-1 drugs are the direct cause of muscle loss is an oversimplification of what the data actually shows. But so is saying these drugs "do not cause muscle loss."

The STEP trials for semaglutide showed that roughly 39% of weight lost was lean mass, which is actually in line with what happens during any caloric-deficit-driven weight loss. That's not great news, but it's not unique to GLP-1s. Wilding et al. (2021, New England Journal of Medicine) reported significant total weight loss but didn't break down muscle preservation in detail. More concerning, a 2023 analysis by Bikou et al. in Nutrients found that without resistance training, patients on GLP-1 agonists lost meaningful amounts of lean body mass alongside fat. So the drug itself isn't the villain, but the drug's appetite suppression can make it easier to under-eat protein and skip the gym, which is the actual villain.

On the GIP and tirzepatide point, there's real science here. Jastreboff et al. (2022, New England Journal of Medicine) showed tirzepatide outperformed semaglutide on weight loss metrics, and GIP receptor activity does appear to play a role in insulin sensitivity and lipid metabolism in muscle tissue.

What did they get wrong (or right)?

He got the headline directionally right: the drug itself is not the primary driver of muscle loss. Credit where it's due. Framing the problem as inadequate protein and no resistance training is accurate and useful advice that a lot of GLP-1 content skips entirely.

Where he goes too far is the flat statement that GLP-1s "do not cause muscle loss." That's not supported by the literature. What the studies show is that muscle loss during GLP-1 therapy is largely driven by the same factors as any weight loss intervention, but GLP-1s can amplify those risks because they suppress appetite so effectively that patients often don't eat enough protein. The drug creates the conditions for muscle loss even if it doesn't directly trigger it at the cellular level.

His tirzepatide GIP claim is the strongest part of the video. The GIP receptor does appear to improve glucose uptake in skeletal muscle, and some researchers believe this is part of why tirzepatide produces better metabolic outcomes than semaglutide alone. However, saying this is definitively beneficial "even in lean people" is a stretch. Most of the trial data comes from individuals with obesity or type 2 diabetes, not lean athletes.

What should you actually know?

If you're on a GLP-1 medication and worried about muscle, here's the realistic picture. Muscle loss during GLP-1 therapy is real but largely preventable with the right behavior. It is not some unique pharmacological effect of the drug destroying your muscle fibers.

Studies like Cava et al. (2017, Advances in Nutrition) consistently show that preserving lean mass during caloric restriction requires two things: adequate protein intake (most guidelines suggest 1.2 to 1.6 grams per kilogram of body weight) and progressive resistance training. GLP-1 drugs suppress your appetite dramatically, which makes it easy to fall short on protein without realizing it. That gap is where the muscle loss comes from.

Tirzepatide's dual GIP and GLP-1 mechanism is genuinely interesting. The GIP component does appear to have distinct effects on muscle and fat tissue compared to GLP-1 alone. But this is an active research area. Calling it a confirmed "positive benefit even in lean people" goes beyond what the current evidence firmly supports.

The bottom line: GLP-1 drugs are powerful tools. They don't automatically destroy muscle, but they can make it much easier to lose muscle if you're not deliberate about nutrition and training. That's a meaningful distinction the video gets mostly right, even if the framing is a little too clean.